India to Poland: Cabazitaxel Export Trade Route
India has recorded 8 verified shipments of Cabazitaxel exported to Poland, representing a combined trade value of $1.1M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $131.9K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED , which accounts for 54% of total export value with 2 shipments worth $573.9K USD. On the buying side, ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest importer in Poland with $573.9K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Cabazitaxel corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $1.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's cabazitaxel manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $131.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with cabazitaxel's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 12.6%, placing it at rank #15 among India's top cabazitaxel export destinations globally.
On the import side, key buyers of Indian cabazitaxel in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP Z O O and 3 others. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the single largest importer with 2 shipments valued at $573.9K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ1
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#15
- Annual growth+12.6%
- Demand growth+13.0%
- Regulatory ease87/100
Top 10 Indian Cabazitaxel Exporters to Poland
Showing top 10 of 4 Indian suppliers exporting Cabazitaxel to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $286.9K per shipment | 2 | $573.9K | 54.4% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $75.7K per shipment | 4 | $302.9K | 28.7% |
| 3 | INTAS PHARMACEUTICALS LTD Avg $178.0K per shipment | 1 | $178.0K | 16.9% |
| 4 | MSN LABORATORIES PRIVATE LIMITED Avg $85 per shipment | 1 | $85 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting cabazitaxel to Poland, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 2 shipments worth $573.9K USD, giving it a 54% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Cabazitaxel Importers in Poland
Showing top 10 of 6 known buyers in Poland receiving Cabazitaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cabazitaxel in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP. Z O.O., TO THE ORDER, among 6 total buyers. The largest importer is ACCORD HEALTHCARE POLSKA SP. Z.O.O. , accounting for $573.9K USD across 2 shipments — representing 54% of all cabazitaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 2 | $573.9K | 54.4% |
| 2 | Accord Healthcare Polska Sp. z o.o. | 1 | $275.1K | 26.1% |
| 3 | ACCORD HEALTHCARE POLSKA SP Z O O | 1 | $178.0K | 16.9% |
| 4 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 1 | $20.7K | 2.0% |
| 5 | TO THE ORDER | 2 | $7.1K | 0.7% |
| 6 | TO THE ORDER OF | 1 | $85 | 0.0% |
Top 10 Cabazitaxel Formulations Imported by Poland
Showing top 10 of 6 product formulations shipped on the India to Poland Cabazitaxel route, ranked by trade value
Poland imports a wide range of cabazitaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML — accounts for $573.9K USD across 2 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML | 2 | $573.9K | 54.4% |
| 2 | PHARMA DRUG&MED: CABAZITAXEL 20MG/ML 3ML | 1 | $275.1K | 26.1% |
| 3 | PHARMA DRUGS & MEDI CABAZITAXEL 20MG/ML 3MLACCORD-PLROCZ AS PER DOCUMENT | 1 | $178.0K | 16.9% |
| 4 | PHARMA DRUG&MED: CABAZITAXEL 20MG/ML 3ML(ACCORD-PLROCZ EACH ML CONTAINS CABAZITAXEL.20.0 MG DEHYDRATED ALCOHOL PH.EUR.39 | 1 | $20.7K | 2.0% |
| 5 | PHARM DRUG&MED:CABAZITAXEL 20MG/ML 3ML(ACCOR-HUNGARY)EACH ML CONTAINS CABAZITAXEL 20MG DEHYDRATED ALCOHOLPH.EU(ASPERINV) | 2 | $7.1K | 0.7% |
| 6 | PLACEBO FOR CABAZITAXEL INJECTION 60MG/1 | 1 | $85 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 4 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's cabazitaxel exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $131.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drug&med: cabazitaxel 20mg/ml 3ml and pharma drugs & medi cabazitaxel 20mg/ml 3mlaccord-plrocz as per document , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest importer with 2 shipments worth $573.9K USD — representing 54% of all cabazitaxel imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $131.9K
- Suppliers
- 4
- Buyers
- 6
- Transit (Sea)
- ~18 days
- Annual Growth
- +12.6%
Related Analysis
Other Cabazitaxel Routes
Unlock the Full India to Poland Cabazitaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 8 shipments on this route.
Frequently Asked Questions — India to Poland Cabazitaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cabazitaxel to Poland?
The leading Indian exporters of Cabazitaxel to Poland are INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Cabazitaxel exports from India to Poland?
India exports Cabazitaxel to Poland worth approximately $1.1M USD across 8 recorded shipments. The average value per shipment is $131.9K USD.
Q Which ports does India use to ship Cabazitaxel to Poland?
The most active port of origin is MUNDRA SEA (INMUN1) with 4 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Poland for Cabazitaxel?
The average transit time for Cabazitaxel shipments from India to Poland is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Poland Cabazitaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.6% with demand growth tracking at 13.0%. The route is ranked #15 among India's top Cabazitaxel export destinations globally.
Q How many suppliers are active on the India to Poland Cabazitaxel route?
There are currently 4 active Indian suppliers exporting Cabazitaxel to Poland. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 54% of total shipment value.
Q Who are the main importers of Cabazitaxel from India in Poland?
The leading importers of Indian Cabazitaxel in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP. Z O.O., TO THE ORDER. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest buyer with 2 shipments worth $573.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Cabazitaxel.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 6 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 8 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists